Menu

GRenSSAP
GRenSSAP

Group leader
avatar_investigadors.jpg
Anna Berenguera Ossó
aberenguera@idiapjgol.org
avatar_grups_recerca.png

Publications

Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infections

C. PÉREZ, S. RUIZ-RIUS, A. RAMÍREZ-MORROS, M. VIDAL, D. OPI, P. SANTAMARIA, J. BLANCO, J. VIDAL-ALABALL, J. BEESON, L. MOLINOS-ALBERT, R. AGUILAR, A. RUIZ-COMELLAS, G. MONCUNILL and C. DOBAÑO
JOURNAL OF INFECTION. 2025 Apr 1; . doi:10.1016/j.jinf.2025.106473; PMID:40113142

  • Year: 01/04/2025
  • FI: 14.3
  • Article

See more:
Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later.

Rubio R, Yavlinsky A, Escalera Zamudio M, Molinos-Albert LM, Martín Pérez C, Pradenas E, Canyelles M, Torres C, Tan C, Swadling L, Ramírez-Morros A, Trinité B, Vidal-Alaball J, Aguilar R, Ruiz-Comellas A, Blanco J, van Dorp L, Balloux F, Dobaño C and Moncunill G
JOURNAL OF INFECTION. 2025 Feb 1; . doi:10.1016/j.jinf.2024.106402; PMID:39746406

  • Year: 01/02/2025
  • FI: 14.3
  • Article

See more:
Prevalence of Dermatomyositis and Polymyositis in Adults and Paediatric Populations: A Network Cohort Study Part of DARWIN EU®

A. PRATS-URIBE, K. LÓPEZ-GÜELL, L. ELHUSSEIN, E. BURN, L. BELLAS, F. DERNIE, A. DELMESTRI, W. MAN, H. OMULO, J. BRASH, H. BALLEGOOIJEN, T. DUARTE-SALLES, N. MERCADÉ-BESORA, L. PEREZ, R. GRIFFIER, S. SEAGER, M. OJA and D. PRIETO-ALHAMBRA
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

See more:
DARWIN EU®-Risk of Thromboembolic Events Associated With COVID-19 During the Omicron Period, and SARS-CoV-2 Vaccination

M. CATALÀ, A. JÖDICKE, K. VERHAMME, M. MOSSEVELD, J. BRASH, S. SEAGER, L. PÉREZ-CRESPO, N. MERCADÉ-BESORA, T. DUARTE-SALLES, M. OJA, E. BURN, A. PRATS-URIBE, D. PRIETO-ALHAMBRA, R. KOLDE and X. LI
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

See more:
Activity of a research ethics committee of primary care

C. JIMÉNEZ, C. FILELLA, C. URGELL, S. GARCÍA, A. HUESO, A. SERRA, A. CAMPOS and R. PEDRÓS
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2024 Oct 1;

See more:

Board of Trustees

Collaborators

Accreditations